Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (69 ops.)
Latest filing published 07 Oct 2026 for Wave Life Sciences Ltd..
Filing timeline
BuySaleChristian O. Henry
Insider track record
Disclosed buys
0
Disclosed sells
69
Signal history
Christian O. Henry: trading record in brief
Christian O. Henry has 96 filings from February 1, 2016 to October 7, 2026 at four companies: Illumina, Inc. (EVP & Chief Commercial Officer, 34), Pacific Biosciences of California, Inc. (See Remarks, 26), Ginkgo Bioworks Holdings, Inc. (Director, 23) and Wave Life Sciences Ltd. (Director, 13).
68 open-market sales total EUR 13,028,494, median EUR 88,124, and there is no purchase. The largest are EUR 2,070,022 on September 16, 2021 at Pacific Biosciences, EUR 1,939,438 on April 13, 2016 at Illumina and EUR 916,754 on September 18, 2023 at Pacific Biosciences. There are also 20 grants and 8 option exercises.
The yearly split is very uneven: 33 filings in 2016, 1 in 2017 and 1 in 2020, then 20 in 2023 and 17 in 2025. Thirteen filings fall in the last twelve months, 8 of them sales. A. Blaine Bowman and Roy A. Whitfield each have 25 trades within 30 days of trades by Christian O. Henry, Paul L. Bianchi 20, Charles Dadswell and Jay T. Flatley 19 each, in the same direction.
Companies and markets linked to Christian O. Henry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations96 total
10,700 shares0Common StockSEC:0001193125-26-417232:0
5,000 shares@ US$7.0810.0050% mcap0.2% of flowClass A Common StockSEC:0001628280-26-062239:0
12,497 shares@ US$1.5140.3% of flowCommon StockSEC:0001299130-26-000043:0
920,810 shares0Common StockSEC:0001299130-26-000037:0
140,874 shares@ US$1.633.1% of flowCommon StockSEC:0001299130-26-000021:1
331,793 shares@ US$1.5760.13% mcap7.4% of flowCommon StockSEC:0001299130-26-000021:0
42,000 shares@ US$5.9711.9% of flowOrdinary SharesSEC:0001193125-25-314740:1
42,000 shares@ US$12.7525.4% of flowOrdinary SharesSEC:0001193125-25-314740:2
15,000 shares@ US$3.502.5% of flowOrdinary SharesSEC:0001193125-25-314740:3
15,000 shares@ US$14.0710.0% of flowOrdinary SharesSEC:0001193125-25-314740:4
30,000 shares@ US$4.596.5% of flowOrdinary SharesSEC:0001193125-25-314740:5
30,000 shares@ US$18.0225.7% of flowOrdinary SharesSEC:0001193125-25-314740:6
6,445 shares@ US$12.7544.6% of flowOrdinary SharesSEC:0001193125-25-314740:0
10,000 shares@ US$11.0617.7% of flowClass A Common StockSEC:0001263805-25-000007:1
10,000 shares@ US$10.920.5% of flowClass A Common StockSEC:0001263805-25-000007:0
9,670 shares@ US$8.814.0% of flowOrdinary SharesSEC:0000950170-25-108287:1
12,700 shares0Ordinary SharesSEC:0000950170-25-108287:0
10,822 sharesClass A Common StockSEC:0001127602-25-017479:0
10,500 shares@ US$9.775.2% of flowOrdinary SharesSEC:0000950170-25-043440:1
10,500 shares@ US$9.1355.4% of flowOrdinary SharesSEC:0000950170-25-043440:0
920,810 shares0Common StockSEC:0001299130-25-000067:0
12,497 shares@ US$1.4070.3% of flowCommon StockSEC:0001299130-25-000048:0
259,909 shares@ US$1.8787.8% of flowCommon StockSEC:0001299130-25-000037:0
98,907 shares@ US$1.7462.6% of flowCommon StockSEC:0001299130-24-000175:0
16,115 shares0Ordinary SharesSEC:0000950170-24-097287:0
25 of 96 declarations
